Andrew Raguskus is the CEO, an electrical engineer and serial entrepreneur. XEnd is his 5th med-tech startup. As Chairman and CEO of Sonic Innovations, he grew revenue from zero to $125 million and rewarded investors with an IPO led by Goldman Sachs in 2001.

Randall Olson, MD, is the AHNS inventor and XEnd's Chief Medical Officer. He is an active eye surgeon, Professor of Ophthalmology at University of Utah, and CEO of the Moran Eye Center.

Strategic planning and performance management executive at the National Institutes of Health and various academic institutions; served as Executive Director of a Center of Excellence and was a business consultant for the Utah Governor’s Office of Economic Development. Co-authored the book, “Research Administration and Management.”

Extensive medical device industry experience with start-ups to billion-dollar companies, including 15-years with Becton Dickenson, where he held titles of VP/GM, and global positions in marketing and business development. Successfully built numerous biotech start-ups from idea/proof-of-principle through successful global commercialization.